Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 8,494,151 | 0 | $512.96M | $426.66M | 18.80% | -$86.30M |
| EyePoint, Inc.(EYPT) | 6,038,235 | 6,893,235 | +855,000 | $139.54M | $142.48M | 6.28% | +$2.94M |
| Arcellx Inc COMMON STOCK | 1,700,000 | 1,780,000 | +80,000 | $94.35M | $123.80M | 5.45% | +$29.45M |
| Alpine Immune Sciences Inc | 2,550,000 | 2,700,000 | +150,000 | $48.60M | $107.03M | 4.72% | +$58.42M |
| BridgeBio Pharma, Inc.(BBIO) | 3,344,179 | 3,203,029 | -141,150 | $135.00M | $99.04M | 4.36% | -$35.97M |
| Praxis Precision Medicines, Inc.(PRAX) | 633,345 | 1,310,000 | +676,655 | $14.11M | $79.94M | 3.52% | +$65.83M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 2,025,000 | +2,025,000 | $0 | $79.46M | 3.50% | +$79.46M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,221,422 | 2,139,102 | -82,320 | $44.98M | $77.76M | 3.43% | +$32.77M |
| Longboard Pharmaceuticals In | 2,353,141 | 3,353,141 | +1,000,000 | $14.19M | $72.43M | 3.19% | +$58.24M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,551,989 | 3,006,534 | +454,545 | $27.92M | $54.84M | 2.42% | +$26.92M |
| Crinetics Pharmaceuticals In | 1,150,000 | 1,150,000 | 0 | $40.92M | $53.83M | 2.37% | +$12.91M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $51.85M | $53.38M | 2.35% | +$1.54M |
| Korro Bio, Inc.(KRRO) | 529,170 | 529,170 | 0 | $25.36M | $47.63M | 2.10% | +$22.26M |
| Vaxcyte, Inc.(PCVX) | 665,000 | 685,000 | +20,000 | $41.76M | $46.79M | 2.06% | +$5.03M |
| Autolus Therapeutics plcADS(AUTL) | 5,450,000 | 6,616,667 | +1,166,667 | $35.10M | $42.21M | 1.86% | +$7.12M |
| Pharvaris N V COM | 1,711,460 | 1,711,460 | 0 | $48.01M | $39.55M | 1.74% | -$8.45M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 1,500,000 | +1,500,000 | $0 | $35.48M | 1.56% | +$35.48M |
| CG Oncology, Inc.(CGON) | 0 | 800,000 | +800,000 | $0 | $35.12M | 1.55% | +$35.12M |
| ALX Oncology Holdings Inc.(ALXO) | 3,142,079 | 3,142,079 | 0 | $46.79M | $35.03M | 1.54% | -$11.75M |
| Biohaven Ltd.(BHVN) | 81,963 | 616,963 | +535,000 | $3.51M | $33.74M | 1.49% | +$30.23M |
| Merus N V | 0 | 715,000 | +715,000 | $0 | $32.20M | 1.42% | +$32.20M |
| Aerovate Therapeutics Inc | 1,211,696 | 1,069,796 | -141,900 | $27.42M | $31.63M | 1.39% | +$4.21M |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 2,130,000 | 0 | $22.79M | $30.46M | 1.34% | +$7.67M |
| Helix Acquisition Corp IiCL A | 0 | 2,909,000 | +2,909,000 | $0 | $30.25M | 1.33% | +$30.25M |
| Marinus Pharmaceuticals Inc | 3,250,000 | 3,250,000 | 0 | $35.33M | $29.38M | 1.29% | -$5.95M |
| Tourmaline Bio Inc | 0 | 1,250,000 | +1,250,000 | $0 | $28.63M | 1.26% | +$28.63M |
| Janux Therapeutics, Inc.(JANX) | 0 | 750,000 | +750,000 | $0 | $28.24M | 1.24% | +$28.24M |
| Neurogene Inc.(NGNE) | 746,180 | 538,714 | -207,466 | $14.46M | $27.42M | 1.21% | +$12.96M |
| Cargo Therapeutics Inc | 1,182,563 | 1,182,563 | 0 | $27.38M | $26.39M | 1.16% | -$981.5K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 550,000 | 550,000 | 0 | $25.28M | $23.83M | 1.05% | -$1.45M |
| Apellis Pharmaceuticals Inc COM | 625,000 | 400,000 | -225,000 | $37.41M | $23.51M | 1.04% | -$13.90M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 2,125,000 | +2,125,000 | $0 | $21.06M | 0.93% | +$21.06M |
| IDEAYA Biosciences, Inc.(IDYA) | 450,000 | 450,000 | 0 | $16.01M | $19.75M | 0.87% | +$3.73M |
| Cabaletta Bio, Inc.(CABA) | 0 | 1,100,000 | +1,100,000 | $0 | $18.77M | 0.83% | +$18.77M |
| Astria Therapeutics Inc | 0 | 1,300,000 | +1,300,000 | $0 | $18.30M | 0.81% | +$18.30M |
| Engene Holdings Inc COM | 0 | 1,000,000 | +1,000,000 | $0 | $16.95M | 0.75% | +$16.95M |
| Insmed Incorporated(INSM) | 575,000 | 575,000 | 0 | $17.82M | $15.60M | 0.69% | -$2.22M |
| Ventyx Biosciences Inc | 0 | 2,710,000 | +2,710,000 | $0 | $14.90M | 0.66% | +$14.90M |
| Nkarta, Inc.(NKTX) | 0 | 1,350,000 | +1,350,000 | $0 | $14.59M | 0.64% | +$14.59M |
| Silence Therapeutics plcADS(SLN) | 0 | 625,000 | +625,000 | $0 | $13.50M | 0.59% | +$13.50M |
| Mersana Therapeutics Inc | 0 | 2,600,000 | +2,600,000 | $0 | $11.65M | 0.51% | +$11.65M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 5,560,300 | +5,560,300 | $0 | $11.01M | 0.49% | +$11.01M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 440,000 | +440,000 | $0 | $10.93M | 0.48% | +$10.93M |
| Immuneering CorpCL A | 4,204,364 | 3,295,273 | -909,091 | $30.90M | $9.52M | 0.42% | -$21.38M |
| Spyre Therapeutics, Inc.(SYRE) | 937,080 | 250,000 | -687,080 | $20.17M | $9.48M | 0.42% | -$10.68M |
| ArriVent BioPharma, Inc.(AVBP) | 0 | 515,000 | +515,000 | $0 | $9.20M | 0.41% | +$9.20M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 450,000 | 300,000 | -150,000 | $13.49M | $8.08M | 0.36% | -$5.40M |
| Disc Medicine, Inc.(IRON) | 125,000 | 125,000 | 0 | $7.22M | $7.78M | 0.34% | +$562.5K |
| Centessa Pharmaceuticals PlcADS | 561,600 | 561,600 | 0 | $4.47M | $6.35M | 0.28% | +$1.88M |
| GH Research PLC(GHRS) | 593,043 | 593,043 | 0 | $3.44M | $6.32M | 0.28% | +$2.88M |
| Stoke Therapeutics, Inc.(STOK) | 1,087,807 | 427,163 | -660,644 | $5.72M | $5.77M | 0.25% | +$44.8K |
| Lantheus Holdings, Inc.(LNTH) | 75,000 | 75,000 | 0 | $4.65M | $4.67M | 0.21% | +$18.0K |
| Verve Therapeutics Inc | 350,000 | 350,000 | 0 | $4.88M | $4.65M | 0.20% | -$231.0K |
| Rapt Therapeutics Inc | 496,750 | 496,750 | 0 | $12.34M | $4.46M | 0.20% | -$7.88M |
| Yarrow Bioscience Inc(YARW) | 1,394,336 | 1,394,336 | 0 | $3.25M | $4.28M | 0.19% | +$1.03M |
| BioAtla, Inc.(BCAB) | 1,181,115 | 1,170,870 | -10,245 | $2.91M | $4.03M | 0.18% | +$1.12M |
| Ambrx Biopharma Inc | 11,231,000 | 0 | -11,231,000 | $159.93M | $0 | — | -$159.93M |
| Axonics Inc | 250,000 | 0 | -250,000 | $15.56M | $0 | — | -$15.56M |
| Cymabay Therapeutics Inc | 1,800,000 | 0 | -1,800,000 | $42.52M | $0 | — | -$42.52M |
| Harpoon Therapeutics Inc | 2,349,060 | 0 | -2,349,060 | $22.55M | $0 | — | -$22.55M |
| Immunovant, Inc.(IMVT) | 1,165,000 | 0 | -1,165,000 | $49.08M | $0 | — | -$49.08M |
| Neumora Therapeutics, Inc.(NMRA) | 92,293 | 0 | -92,293 | $1.57M | $0 | — | -$1.57M |
| Olema Pharmaceuticals, Inc.(OLMA) | 2,456,800 | 0 | -2,456,800 | $34.47M | $0 | — | -$34.47M |
| Rayzebio Inc | 1,213,478 | 0 | -1,213,478 | $75.44M | $0 | — | -$75.44M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,175,000 | 0 | -1,175,000 | $25.39M | $0 | — | -$25.39M |